TP53 and cancer: •Epigenetics (e.g. DNA methylation changes in H. pylori or HPV E6 oncogene resulting in P53 degradation), as well as mutational signatures•Mutation effects (stimulating cellular mutations promoting cancer)•Stimulating immune evasion mechanisms reducing immunosurveillance for emerging cancer cellsIntegration of microbial DNA into host genome